Login / Signup

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma.

Maria Christina CoxMarta BanchiSabrina PellicciaArianna Di NapoliLuigi MarcheselliCaterina PattiPaola Anticoli BorzaRoberta BattistiniFrancesca Di GregorioPaola OrlandiGuido Bocci
Published in: Cancer chemotherapy and pharmacology (2020)
All-oral DEVEC showed an encouraging activity and acceptable toxicity. This schedule deserves further studies in elderly PTCL also for assessing combinations with targeted drugs.
Keyphrases
  • middle aged
  • community dwelling
  • oxidative stress
  • cancer therapy
  • case control
  • chemotherapy induced